![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/08/01/2922414/0/en/Pharming-Group-reports-second-quarter-and-first-half-2024-financial-results-and-provides-business-update.html
https://www.globenewswire.com/news-release/2024/07/18/2915041/0/en/Pharming-Group-to-report-second-quarter-and-first-half-2024-financial-results-on-August-1.html
https://www.globenewswire.com/news-release/2024/06/03/2891914/0/en/Pharming-Group-to-participate-in-June-investor-conferences.html
https://www.globenewswire.com/news-release/2024/05/30/2891174/0/en/Pharming-Group-provides-update-on-ongoing-regulatory-review-of-leniolisib-for-the-treatment-of-APDS-in-the-European-Union.html
https://www.globenewswire.com/news-release/2024/05/21/2885849/0/en/Pharming-Group-reports-on-results-of-the-2024-Annual-General-Meeting-of-Shareholders.html
https://www.globenewswire.com/news-release/2024/05/20/2884617/0/en/Pharming-Group-to-participate-in-May-investor-conference.html
https://www.globenewswire.com/news-release/2024/05/15/2882055/0/en/Pharming-Group-announces-the-early-redemption-of-the-remaining-outstanding-125-million-convertible-bonds-due-2025.html
https://www.globenewswire.com/news-release/2024/05/08/2877415/0/en/Pharming-Group-reports-first-quarter-2024-financial-results-and-provides-business-update.html
https://www.globenewswire.com/news-release/2024/04/24/2868290/0/en/Pharming-Group-to-report-first-quarter-2024-financial-results-on-May-8.html
https://www.globenewswire.com/news-release/2024/04/24/2868259/0/en/Pharming-to-be-honored-as-Industry-Innovator-at-National-Organization-for-Rare-Disorders-NORD-2024-Rare-Impact-Awards.html